Emcure Pharmaceuticals consolidated net profit rises 42.05% in the June 2026 quarter
(06 Aug 2026)

Back
Net profit of Emcure Pharmaceuticals rose 42.05% to Rs 293.98 crore in the quarter ended June 2026 as against Rs 206.95 crore during the previous quarter ended June 2025. Sales rose 22.85% to Rs 2580.45 crore in the quarter ended June 2026 as against Rs 2100.54 crore during the previous quarter ended June 2025.

ParticularsQuarter Ended
Jun. 2026Jun. 2025% Var.
Sales2580.452100.54 23
OPM %20.6419.84 -
PBDT503.03393.71 28
PBT393.53294.26 34
NP293.98206.95 42

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew